Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bruno Larvol
Observed name:
B. Larvol
Institution:
LARVOL (United States)
Observed institution:
LARVOL (United States)
ORCID:
0009-0006-0908-9947
Observed ORCID:
0009-0006-0908-9947
OpenAlex ID:
A5043046993
Nectin-4 expression patterns and therapeutics in oncology
2025
·
Mina Nikanjam
, Judith Pérez-Granado
, et al.
·
Cancer Letters
·
40
Claudin 18.2 Targeting: A Pan-Cancer Perspective
2026
·
Mina Nikanjam
, Judith Pérez-Granado
, et al.
·
Clinical Cancer Research
·
2
PDF
Reliance of agency-approved and guideline-recommended therapies on surrogate endpoints in triple-negative breast cancer (TNBC).
2023
·
Kinisha Gala
, Ankit Kalucha
, et al.
·
Journal of Clinical Oncology
·
1
174P A multi-LLM framework for oncology clinical decision support: A breast cancer case series
2026
·
M.S. Shaikh
, D. Biswas
, et al.
·
Annals of Oncology
128P Multi-LLM–assisted trial selection for network meta-analysis in first-line extensive-stage small cell lung cancer
2026
·
S. Parveen
, D. Medin
, et al.
·
Annals of Oncology
127P LLM-based evidence scoring framework: 1L non-exon 20 EGFR-mutated advanced NSCLC as a case study
2026
·
R. Thakur
, D. Jaramillo
, et al.
·
Annals of Oncology
134P A consensus-based large language model approach for predicting oncology clinical trial efficacy outcomes
2026
·
D. Wilkerson
, Y. Krishnaveni
, et al.
·
Annals of Oncology
263eP Treatment decision-making in multiple myeloma: Comparison of AI models with expert myeloma oncologists
2026
·
J. Pérez-Granado
, M. Nikanjam
, et al.
·
Annals of Oncology
363P Generation of synthetic patient survival data from trial-level metadata using machine learning
2026
·
R. Gupta
, S. Rai
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
350P Control-arm appropriateness in breast cancer randomized trials: An LLM framework integrating trial data and oncologist posts on X
2026
·
A. Kalucha
, D. Campanella
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
348P A multi-large language model framework for multidimensional oncology treatment market Mapping: First-line metastatic squamous NSCLC
2026
·
K.D. Narisetty
, D. Campanella
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
P1.369: COMPLIMA: A Multi-LLM Framework for AI-Assisted Oncology Decision Support - a Lung Cancer Case Series
2026
·
D. Biswas
, J. Pérez-Granado
, et al.
·
Journal of Thoracic Oncology
P3.238: Evaluating AI Decision Support in EGFR-Mutated, ALK-Positive, or ROS1-Positive Metastatic NSCLC
2026
·
N. Peruzzo
, C. Jani
, et al.
·
Journal of Thoracic Oncology
P1.242: When AI Meets Oncologist Judgment: Evaluating Decision Support in Advanced NSCLC Across Genomic Subtypes
2026
·
T. Lavorgna
, C. Jani
, et al.
·
Journal of Thoracic Oncology
AI-powered social media listening of oncologist conversations at ASCO 2025.
2026
·
Sandeep Ghosal
, Bruno Larvol
, et al.
·
Journal of Clinical Oncology
Predicting progression-free and overall survival from response endpoints in oncology clinical trials: An embedding-based machine learning approach.
2026
·
Ankit Kalucha
, Judith Pérez Granado
, et al.
·
Journal of Clinical Oncology
Predicting 12-month overall survival from response rate and 6-month progression-free survival in oncology clinical trials: An embedding-based machine learning approach.
2026
·
Ankit Kalucha
, Judith Pérez Granado
, et al.
·
Journal of Clinical Oncology
Treatment strategies in metastatic NSCLC after progression to immuno-chemotherapy: A random-effects network meta-analysis of phase III trials.
2026
·
Judith Pérez Granado
, Luca Cantini
, et al.
·
Journal of Clinical Oncology
PDF
Evaluating AI decision support in a rapidly evolving therapeutic landscape: EGFR -mutant metastatic NSCLC.
2026
·
Chinmay Jani
, Judith Pérez-Granado
, et al.
·
Journal of Clinical Oncology
525P Robustness of LLM-assisted network meta-analysis in second-line or later HER2-positive metastatic breast cancer: A cross-model validation study
2026
·
S. Parveen
, D. Medin
, et al.
·
ESMO Open
421P AI for real-time identification of high-impact clinical trials at oncology conferences
2025
·
A. Kalucha
, J. Pérez-Granado
, et al.
·
ESMO Real World Data and Digital Oncology
P3.13.18 Immunotherapy Pooled Analysis in 1L Extensive-Stage Small Cell Lung Cancer
2025
·
J. Pérez-Granado
, M. Gramling
, et al.
·
Journal of Thoracic Oncology
1491P Pooled analysis in first-line HCC: Immune checkpoint inhibitor vs tyrosine kinase inhibitor regimens
2025
·
J. Pérez Granado
, M. Gramling
, et al.
·
Annals of Oncology
Abstract P5-05-11: Systematic review of ADCs vs chemotherapy in 2L+ Her2+ mBC
2025
·
Bruno Larvol
, Mark Gramling
·
Clinical Cancer Research
Systematic review of BCMA-targeted therapies in relapsed/refractory (R/R) multiple myeloma (MM).
2025
·
Judith Pérez-Granado
, Kamal S. Saini
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
32
Citation count:
43
H-index:
2
I10-index:
1
Year
Topic
Type